At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Sorted Ascending Name Title Type Shares Traded Price Range
Apr 1, 2008 palling david Officer Automatic Sell 1,250 11.00 - 11.25
Apr 2, 2008 crowley john f Officer Automatic Sell 5,800 10.86 - 11.25
Apr 3, 2008 crowley john f Officer Automatic Sell 1,800 11.00 - 11.06
Apr 14, 2008 patterson matthew r Officer Automatic Sell 500 10.74 - 10.76
Apr 14, 2008 patterson matthew r Officer Automatic Sell 5,500 10.00 - 10.73
Apr 15, 2008 patterson matthew r Officer Automatic Sell 3,422 10.00 - 10.38
Apr 16, 2008 patterson matthew r Officer Automatic Sell 578 10.00
Apr 24, 2008 palling david Officer Option Execute 20,000 0.64
May 1, 2008 crowley john f Officer Automatic Sell 5,205 10.34 - 10.88
May 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
May 2, 2008 crowley john f Officer Automatic Sell 4,795 10.26 - 10.72
Jun 2, 2008 crowley john f Officer Automatic Sell 1,300 10.12 - 10.29
Jun 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.20
Jun 3, 2008 crowley john f Officer Automatic Sell 3,700 10.08 - 10.44
Jun 4, 2008 crowley john f Officer Automatic Sell 5,000 10.29 - 10.50
Jun 16, 2008 patterson matthew r Officer Automatic Sell 4,900 11.12 - 11.25
Jun 17, 2008 patterson matthew r Officer Automatic Sell 1,800 11.00 - 11.20
Jun 18, 2008 patterson matthew r Officer Automatic Sell 1,500 10.95 - 11.12
Jun 19, 2008 patterson matthew r Officer Automatic Sell 400 11.02 - 11.11
Jun 20, 2008 patterson matthew r Officer Automatic Sell 1,400 11.25 - 11.54
Showing 181-200 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy